Medicine Apr 20
Analyses of the EXPAND study showed that siponimod (BAF312) reduced the risk of disability progression largely disassociated from relapses in patients with secondary progressive multiple sclerosis (SPMS) -   In EXPAND, siponimod also had a meaningful benefit on patients' cognitive processing speed -   Findings add to clinical evidence for siponi
Social Sciences Apr 19

Algorithms are used to personalize our newsfeed on social media. But the risk is that the points of view we are presented with become increasingly limited and extreme.

Astronomy Apr 17

Using transmission electron microscopy, EPFL scientists have examined a slice from a meteorite that contains large diamonds formed at high pressure.

    Selected Job Offers
    Employers of the Week